Evidence map›Paper›PMID 31384459›Full record

ArticleMolecular and clinical oncology2019

Prognostic significance of the postoperative level and recovery rate of serum albumin in patients with curatively resected pancreatic ductal adenocarcinoma.

Yutaka Nakano, Minoru Kitago, Masahiro Shinoda, Hiroshi Yagi, Yuta Abe, Kiminori Takano, Go Oshima, Ayano Takeuch, Yutaka Endo, Yuko Kitagawa

Abstract read
In one paragraph

Article in Molecular and clinical oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yutaka NakanoDepartment of Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan.
Minoru KitagoDepartment of Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan.
Masahiro ShinodaDepartment of Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan.
Hiroshi YagiDepartment of Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan.
Yuta AbeDepartment of Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan.
Kiminori TakanoDepartment of Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan.
Go OshimaDepartment of Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan.
Ayano TakeuchDepartment of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo 160-8582, Japan.
Yutaka EndoDepartment of Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan.
Yuko KitagawaDepartment of Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to investigate the clinicopathological features and prognostic factors associated with pre- and postoperative serum albumin levels in patients with curatively resected pancreatic ductal adenocarcinoma (PDAC). To achieve this, the data of patients who underwent pancreatectomy for PDAC between January 1995 and March 2016 were retrospectively reviewed, and the pre- and postoperative serum albumin levels at postoperative months (POMs) 3, 6, and 12 were evaluated. The serum albumin recovery rate was also investigated. A total of 196 patients were enrolled in the present study. In the multivariate Cox regression analysis, lymph node metastasis [hazard ratio (HR): 1.65; P=0.022], serum albumin level at POM 12 (≥3.9 g/dl; HR: 0.60; P=0.017), and serum albumin recovery rate at POM 12 (≥1.00; HR: 0.60; P=0.017) were independent prognostic factors for disease-free survival. Lymph node metastasis (HR: 1.79; P=0.013) and serum albumin level at POM 12 (≥3.9 g/dl) (HR: 0.60; P=0.033) were independent prognostic factors for overall survival. These results indicated that the postoperative level and recovery rate of serum albumin are potential biomarkers for predicting the prognosis of patients with curatively resected PDAC. However, further studies are required in order to investigate the survival benefit of increasing postoperative serum albumin levels in these patients.

Indexed as

biomarkerpancreatic cancerprognosisserum albuminsurvival

Identifiers

PMID31384459
PMCPMC6636208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.